Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 16.91% |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 27.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.06% |
| Dec 31, 2025 | 69.12% |
| Sep 30, 2025 | -32.02% |
| Jun 30, 2025 | 44.35% |
| Mar 31, 2025 | 49.79% |
| Dec 31, 2024 | -181.34% |
| Sep 30, 2024 | -42.16% |
| Jun 30, 2024 | 33.27% |
| Mar 31, 2024 | 56.08% |
| Dec 31, 2023 | 87.59% |
| Sep 30, 2023 | 74.63% |
| Jun 30, 2023 | -367.26% |
| Mar 31, 2023 | -191.21% |
| Dec 31, 2022 | 195.98% |
| Sep 30, 2022 | -863.18% |
| Jun 30, 2022 | -57.26% |
| Mar 31, 2022 | -115.84% |
| Dec 31, 2021 | -33.52% |
| Sep 30, 2021 | -69.87% |
| Jun 30, 2021 | -48.65% |